Intelligence Β· Clinical Pipeline

HALOZYME THERAPEUTICS Pipeline

All ClinicalTrials.gov programs at HALOZYME THERAPEUTICS β€” phase, modality, and trial IDs.

Programs
3

Quick answer

HALOZYME THERAPEUTICS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Hylenex

    HALOZYME THERAPEUTICS, INC.

    Pain

    phase 3 small molecule completed

    1 trial
  2. Placebo

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Ductal Carcinoma

    phase 3 small molecule terminated

    1 trial
  3. Testosterone enanthate

    HALOZYME THERAPEUTICS, INC.

    Hypogonadism, Male

    phase 3 other active

    1 trial

Frequently asked questions

How many pipeline programs does HALOZYME THERAPEUTICS have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs